Infectious diseases and anemia in a sample of out-of-treatment drug users

American Journal of Managed Care

Volumn 4, Issue 9 SUPPL., 1998, Pages 1257-1264

  Montoya, Isaac D ^a,b  

^a Affiliated Systems Corporation   (United States)

^b Systems Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; UNITED STATES;

ADULT; AGED; ANEMIA; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS; SYPHILIS; TEXAS;

EID: 0031670793     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. On Managed Care [newsletter]. HMDs' not-so-pretty profit picture, 3,1. January 1988.
2. Montoya ID, Chenier EE, Richard AN. Drug abuse, AIDS, and the coming crisis in long term care. J Nitrs Manage 1996;4:151-162.
3. Williams ML, Elvvood WN, Weatherby NL, et al. An assessment of the risks of syphilis and HIV infection among a sample of out-of-treatment drug users. AIDS Care 1996;8:671-682.
4. Hopkins RJ, Rothman M, Fiore A, Golclblum SE. Cerebral mucomycosis associated with intravenous drug use: Three case reports and review. Clin Infect Dis 1994;19:677-681.
5. Duesberg PH. The role of drugs in the origin of AIDS. Biomed Pharmacother 1992;46:3-15.
6. Kelen CD, Fleetwood, D. HIV infection and intravenous drug users; implications for emergency services. Emerg Med Clin North Am 1990;8:738-751.
7. Brown LS, Hickson MJ, Ajuluchukwu DC, Bailey J. Medical disorders in a cohort of New York City drug abusers: Much more than HIV disease. J Infect Dis 1993;12:11-27.
8. Curtiss MA, Lenz KM, Frei NR. Medical evaluation of African American \vomen entering drug treatment. J Addict Dis 1993;12:29-44.
9. Singh BK, Koman JJ III, Williams JS, Catan VM, Souply JL. Sex differences in self-report of physical health by IDUs. Int J Addict 1994;29:275-283.
10. Davis JA, Smith TW. General Social Surveys, 1972-1990. Chicago, IL: National Opinion Research Center; 1991.
11. Carlson R, Wang J, Siegal H, Falck R, Guo J. An ethnographic approach to targeted sampling and solution in AIDS prevention research among injection drug and crack-cocaine users. Hum Organ 1994;53:279-286.
12. Walters J, Biernacki P. Targeted sampling: Options for the study of hidden populations. Social Problems 1989; 36:416-430.
13. Pattison P, Wasserman S. Constructing algebraic models for local social networks based on statistical methods. J Matltl Psyclwl 1995;39:57-72.
14. Weatherby N, Needle R, Cesari H, et al. Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Eval Program Plann 1994;17:347-355.
15. Dovvling-Guyer S, Johnson M, Fisher D, et al. Reliability of drug users' self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment 1994;1:383-392.
16. Coyle S. The N1DA Standard Intervention Model for Injection Drug Users Oiit-of-treatment. Rockville, MD: National Institute on Drug Abuse; 1993.
17. Spivak JL, Selonick SE, Quinn TC. Acquired immune deficiency syndrome and pancytopenia. ]AMA 1983; 250:3084-3087.
18. Centers for Disease Control. HIV/AIDS Surveillance Report. Atlanta: Centers for Disease Control;. 1995.
19. Abrams D. AIDS update-1987. Adv Alcohol Subst Abuse 1987;7:29-45.
20. Quinn T, Classer D, Cannon R, et al. Human immunodeficiency virus among patients attending clinics for sexually transmitted diseases. N Engl ] Mcd 1988;318:197-203.
21. Quinn T, Cannon R, Croseclose S, et al. The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics. Arch Intern Med 1990;150:1297-1302.
22. Sterk C. Cocaine and seropositivity. Lancet 1988; 1(8593):1052-1053.
23. Trapido E, Lewis N, Comerford M. HIV related and non-related diseases among IV drug users and sexual partners. J Drug Issues 1989;20:245-266.
24. Stroffolini T, Corona R, Giglio A, et al. Risk factors for hepatitis B virus infection among homosexual men attending a sexually transmitted disease clinic in Italy. New Microbiol 1997;20:333-338.
25. Herrera GA, Lackritz EM, Janssen RS, et al. Serologie test for syphilis as a surrogate marker for human immunodeficiency virus infection among United States blood donors. Transfusion 1997;37:836-840.
26. Booth R, Watters J. How effective are risk-reduction interventions targeting injecting drug users? AIDS 1994;8: 1515-1524.
27. Friedman S, Des Jarlais D, Ward T, et al. Drug injectors and heterosexual AIDS. In: Sherr L, ed. AIDS and the Heterosexual Population. Langhorne, PA: Harwood; 1994: 41-65.
28. Stephens R, Simpson D, Coyle S, McCoy C, the National AIDS Research Consortium. Comparative effectiveness of NADR interventions. In: Brown B, Beschner B, eds. Handbook on Risk of AIDS: Injection Drug Users and Sexual Partners. Westport, CT: Greenwood Press; 1993:519-556.
29. Siegal H, Carlson R, Falck R, Forney M, Wang J. Highrisk behaviors for transmission of syphilis and human immunodeficiency virus among crack cocaine-using women. SexTransm Dis 1992;19:266-271.
30. Brown B, Needle R. Modifying the process of treatment to meet the threat of AIDS. Int J Addict 1994;29:1739-1752.
31. Bell D, Richard A, Dayton C. Effect of drug treatment on psychosocial change among cocaine users: A comparison of intreatment and out-of-treatment change. Substance Use and Misuse 1996;31:1083-1100.
32. Levin SM, Trumble JG, Edmunds M, Statman JM, Petersen RC. Perspectives on linkage of primary health care, and substance abuse treatment. J Addict Dis 1993;12:1-8.
33. Wiebel WW, Booth R, Brewster JT,.Koester R. Risk reduction through indifenous outreach to intravenous drug users. In: Harris L, ed. Problems of Drug Dependence 1991. Washington, DC: Superintendent of Documents, US Government Printing Office; 1992;299.